imageSlide
Media
100px
medium
Woman with dark hair laughing
spacer
large
spacer
large
spacer
large
spacer
small
spacer
large
spacer
large

Ebglyss® (lebrikizumab-lbkz)
32px
FDA-Approved Treatment for Moderate-to-Severe Atopic Dermatitis
20px
Read more
link
Read Ebglyss's Media Kit

Jaypirca® (pirtobrutinib)
32px
First and Only Non-Covalent (Reversible) BTK Inhibitor Approved by the U.S. FDA for Adult Patients with CLL or SLL Who Have Received at Least Two Lines of Therapy,
20px
Read more
link
Read Jaypirca's Media Kit
spacer
large
spacer
large

Mounjaro® (tirzepatide)
32px
The First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes.
20px
Read more
link
Read Mounjaro's Media Kit

Omvoh® (mirikizumab-mrkz)
32px
FDA-Approved Treatment for Two Types of Inflammatory Bowel Disease
20px
Read more
link
Read Omvoh's Media Kit
spacer
large
spacer
large
Zepbound® (tirzepatide)
32px
Zepbound is an injectable prescription medicine that may help adults with obesity or moderate-to-severe obstructive sleep apnea.
20px
Read more
link
Read Zepbound's Media Kit
spacer
large
OTHER REQUESTS
Looking for something else?
60px
You can request additional B-roll footage or executive biography images by emailing us here.
If you are a customer and have questions regarding Lilly medicines, please call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).
20px
spacer
large
center
Social media guidelines
48px
View our corporate social media guidelines. We look forward to connecting and engaging with you.
24px
Read the guidelines
link
Read the social media guidelines